Cerecor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cerecor and buy or sell other stocks, ETFs, and their options commission-free!About CERC
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.
CEOGarry Arthur Neil, MD
CEOGarry Arthur Neil, MD
Employees23
Employees23
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2011
Founded2011
Employees23
Employees23
CERC Key Statistics
Market cap52.23M
Market cap52.23M
Price-Earnings ratio-2.10
Price-Earnings ratio-2.10
Dividend yield—
Dividend yield—
Average volume379.99K
Average volume379.99K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.72
52 Week high$20.72
52 Week low$3.39
52 Week low$3.39
Stock Snapshot
As of today, Cerecor(CERC) shares are valued at $2.93. The company's market cap stands at 52.23M, with a P/E ratio of -2.10.
On 2025-12-28, Cerecor(CERC) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Cerecor(CERC) stock has reached 0, versus its average volume of 379.99K.
The stock's 52-week range extends from a low of $3.39 to a high of $20.72.
The stock's 52-week range extends from a low of $3.39 to a high of $20.72.
People also own
Based on the portfolios of people who own CERC. This list is generated using Robinhood data, and it’s not a recommendation.